Home » Business Information » Costs & Rebates » MTPConnect REDI Subsidy

A new funding partnership between APR.Intern and MedTech and Pharma Growth Centre (MTPConnect) will increase workforce capabilities and strengthen research translation within Australia’s medtech, biotech and pharmaceutical sector.

Under the agreement, MTPConnect’s REDI initiative will provide 20 businesses in the medtech, biotech and pharmaceutical sector with the opportunity to take on a PhD student through a short-term research placement and benefit from an additional $10,000 subsidy to ease the cost. Facilitated by APR.Intern, the PhD research placements enable innovative businesses to engage with Australia’s brightest emerging research talent. For universities, the placements support the development of an industry-ready PhD workforce.

Businesses can also benefit from APR.Intern’s Australian Government 50% rebate. Together with the $10,000 MTPConnect REDI subsidy, this covers the entire net cost of a full-time 3-month research project.

This partnership falls under MTPConnect’s $32 million Researcher Exchange and Development within Industry (REDI) initiative made possible by the Medical Research Future Fund, providing industry experiences and skills development for early and mid-career researchers, clinicians and innovators to develop an industry ready workforce keeping pace with the demands of a rapidly changing sector. 

PROJECT COSTS

MTPConnect REDI Subsidy

3-MONTH PROJECT COST: $20,000

UPFRONT COMMITMENT FOR THE BUSINESS: $20,000

GOV. REBATE TO BUSINESS: $10,000

MTPCONNECT REDI SUBSIDY: $10,000

NET COST TO BUSINESS: $0

Project cost includes a $3,000 monthly student scholarship, a one-off $5,500 academic mentor fee and a one-off $5,500 project management fee.

3 month project normally $20,000; $0 net cost with rebate and MTPConnect subsidy
4 month project normally $23,000; $1,500 net cost with rebate and MTPConnect subsidy
5 month project normally $26,000; $3,000 net cost with rebate and MTPConnect subsidy

INTERNSHIP BENEFITS

COST-EFFECTIVE

  • Access to PhD-level research expertise
  • Used for controlled practice growth
  • Suitable to fill short-term skills gaps
  • Eligible for R&D tax incentive

RAPID RESULTS

  • Results-driven 3-6 month projects
  • Quick turnaround on establishment
  • Responsive to changing business needs and priorities

HASSLE FREE

  • IP stays with business
  • No employment requirements
  • Pre-approved contract
  • Simple and transparent model
  • Proven and trusted model

INDUSTRY ELIGIBILITY

  • Proposal must have medtech, biotech or pharmaceutical relevance
  • One MTPConnect REDI subsidy per business
  • Project subject to MTPConnect review and approval

FOR MORE INFORMATION

Michael Valentine
Business Development Officer, APR.Intern

0411 600 063
m.valentine@aprintern.org.au